SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CNSI Cambridge Neuroscience

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (529)1/27/2000 10:29:00 AM
From: Mike McFarland  Read Replies (2) of 675
 
Okay now--Just had a nice chat with Harry Wilcox,
pres/CEO of CNSI. Not just the play on GGF2 for MS
(which Bayer funds entirely) but also diabetic neuropathy
might be the next indication for GGF2--very early work
of course and anything that deals with remylenation of
the nerve cells is a candidate.

Anyway, that was not the point to pestering these fellas--
I got more specific information on the migrane patch--we
should see enrollment into phase II this year and CNSI
is looking at other patch companies--so if it doesn't
turn out to be Alza, that just means they got a better
price elsewhere. We may see phase II with IV delivery
also for 5161. Actually, I already had some of this
information, but I wanted to confirm it and get it on
the thread now with the shareprice trending up, maybe
help grease things along, $2 seems a notch too cheap.

Wilcox said that they should be able to go a couple years
without having to raise cash, but eventually they would
look to do that, so that sounds to me like they wont be
selling out to anybody and we can retire the YukonHusky
rumor. Of course we can always hope to get cashed out
early, but I did not get any hints to that effect.
He also confirmed that $4 was the magic number to get
off the otcbb, I guess I will take his word for it, and
so just for fun, I will make $4 my target for the shareprice.

Hopefully milestone payments here and there (Allergan)
will keep an occasional press release coming out of CNSI,
and we will hear good news in the months and years ahead.

When my Neuroinvestment trial starts up, don't be surprised
if I stop posting to the thread. I just got a bee in my
bonnet and made the call because I was so peterbed at the
trading on the otcbb--but if I resist churning my account,
then that wont be a factor, and if Dr. Tracy keeps tabs
on CNSI, and he does, I wont be making any more calls.
Great fun to talk to the head honcho though:-)

Oh, I should point out that Alza saw data on 5161 at a
meeting and went to CNSI--that sounds like a plus, that
they went out of their way to track down CNSI instead
of the other way around. Just my two cents.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext